• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    京

    京都市立病院

    Kyoto City Hospital
    EST. 1965
    938论文总数
    1.4万引用总数

    论文量&引用量时间轴

    机构学者

    论文(938)

    年份
    起
    –
    止
    排序
    1Clinical Outcomes of Postoperative Radiotherapy with Regional Nodal Irradiation Excluding Internal Mammary Lymph Nodes in Breast Cancer: a Multi-Institutional Retrospective Analysis
    Kanako Nakatsu, Yuka Ono,Michio Yoshimura,Kimiko Hirata,Chikako Yamauchi,Masakazu Ogura,Takahiro Kishi,Kota Fujii,Shuji Ohtsu,Takashi Sakamoto, Kazuhito Ueki, Kengo Ogura,

    Background Postoperative regional nodal irradiation (RNI) is a standard treatment for breast cancer at high risk of regional recurrence; however, the necessity of including the internal mammary node (IMN) region in the radiation field remains unclear. This study aimed to evaluate treatment outcomes in a large cohort of patients who received postoperative radiotherapy with RNI excluding the IMN region. Methods This study included patients with breast cancer who underwent surgery followed by RNI without IMN irradiation between 2007 and 2018. The primary endpoint was disease-free survival (DFS), and the secondary endpoints were overall survival (OS), breast cancer-specific mortality (BCM), distant metastasis-free survival (DMFS), recurrence patterns, and treatment-related adverse events. Results In total, 799 patients were included. The 5-year DFS, OS, BCM, and DMFS rates were 75.9, 88.3, 9.7, and 77.1%, respectively. Worse outcomes were associated with a higher number of positive lymph nodes and estrogen receptor (ER)-negative disease. Medial/central tumor location and younger age were each significantly associated with poorer outcomes, being associated with worse DFS and DMFS. Bone was the most common recurrence site. ER-negative disease, a higher number of positive lymph nodes, medial/central location, and younger age were significant risk factors for recurrence, particularly distant metastasis. IMN recurrence was rare. Conclusions In this cohort, medial/central tumor location, ER-negative disease, and extensive nodal involvement were associated with poorer outcomes, suggesting that these factors may identify patients who can benefit from IMN irradiation. These findings may serve as important reference data when determining the indication for IMN irradiation on an individual patient basis.

    2026Breast Cancer(2026)引用:26
    引用
    AI阅读
    加入学术空间
    2Persistent Homology Analysis of Longitudinal Computed Tomography Fibrotic Features in COPD.
    Yusuke Shiraishi,Naoya Tanabe,Shizuo Kaji,Ryo Sakamoto,Tomoki Maetani, Yoshihiro Seri,Satoru Terada,Kunihiko Terada,Tsuyoshi Oguma,Motonari Fukui,Shigeo Muro,Tomohiro Handa,

    BACKGROUND:Fibrosis may coexist with emphysema in COPD, but computed tomography (CT) quantification is challenging. Persistent homology (PH), a topological data analysis technique, provides interpretable structural features in greyscale images. By using PH, this CT study aimed to quantify fibrotic lesions in nonemphysematous and emphysematous lungs and to investigate clinical implications of PH-based fibrosis quantification in patients with COPD. METHODS:The study included subjects from the Lung Cancer Screening (LCS) cohort (n=346) and two prospective COPD cohorts (Kyoto University n=234; Kyoto-Himeji n=166). Based on CT value patterns and spatial topology, PH assigned each voxel as fibrotic or nonfibrotic and calculated the percentage of fibrotic lung volume (PH-fibrosis%) in association with visually identified interstitial lung abnormality and COPD outcomes. RESULTS:Higher PH-fibrosis% was associated with interstitial lung abnormalities in the LCS and Kyoto University cohorts. The two COPD cohorts consistently showed significant associations between higher baseline PH-fibrosis% and future exacerbation risk independent of emphysema and airway wall thickness (hazard ratio (HR) 1.39 and 3.35 for Kyoto University and Kyoto-Himeji, respectively). In the Kyoto University cohort, higher PH-fibrosis% was significantly associated with increased mortality (HR 1.94), with a similar trend in the Kyoto-Himeji cohort (HR 1.86). Longitudinal increases in PH-fibrosis% over median 4.98 years were associated with higher exacerbation frequency and patients experiencing greater increase in PH-fibrosis% subsequently exhibited higher mortality in the Kyoto University cohort. CONCLUSIONS:PH can be used to quantify fibrotic lesions on CT and PH-fibrosis% could be a prognostic imaging marker in patients with COPD.

    2026The European respiratory journal(2026)引用:2
    引用
    AI阅读
    加入学术空间
    3Prognostic Impact of Major Pathologic Response after Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Retrospective Study of 739 Cases.
    Kei Yamane,Kazuyuki Nagai,Takayuki Anazawa,Yosuke Kasai,Asahi Sato,Yu Hidaka, Yumiko Ibi, Toshihiko Masui,Yuichiro Uchida,Kazuhiko Kitaguchi,Shintaro Yagi, Yusuke Okamura,

    OBJECTIVE:We evaluated the prognostic significance and implications of a major pathologic response (MPR) after preoperative treatment for pancreatic ductal adenocarcinoma (PDAC). SUMMARY BACKGROUND DATA:Preoperative treatment is increasingly used for PDAC to improve oncologic outcomes. The pathologic response represents a potential indicator of treatment efficacy; however, its prognostic value in PDAC remains unclear. METHODS:We retrospectively analyzed 739 patients who underwent pancreatectomy for PDAC after preoperative treatment at 21 institutions in Japan. The pathologic response was graded using Evans' classification, with MPR defined as Evans grade III/IV. Survival outcomes and prognostic factors were evaluated, and factors associated with achieving MPR were analyzed to develop a predictive model. RESULTS:MPR was achieved in 11.5% of patients. The MPR group had a significantly longer median overall survival (71.5 vs. 40.9 mo) and recurrence-free survival (55.5 vs. 15.2 mo) than the non-MPR group. Multivariate analysis identified MPR as an independent prognostic factor for overall survival. In the MPR subgroup, neither overall nor recurrence-free survival differed according to adjuvant chemotherapy administration; multivariate analysis did not identify adjuvant therapy as an independent prognostic factor. Predictive factors for achieving MPR included chemoradiotherapy, preoperative duration ≥6 months, normal carbohydrate antigen 19-9 after preoperative treatment, and complete or partial radiologic response. Finally, we developed a simplified predictive model for achieving MPR. CONCLUSIONS:MPR was independently associated with favorable survival in PDAC. The prognostic impact of adjuvant chemotherapy was not observed among patients who achieved MPR, suggesting that MPR may inform individualized postoperative management and warrants prospective validation.

    2026Annals of surgery(2026)引用:1
    引用
    AI阅读
    加入学术空间
    4Clinical Impact of PCSK9 Inhibitor Discontinuation on Cardiovascular Outcomes ― Real-World Evidence from the Kyoto PCSK9 Registry ―
    Hideo Tsubata,Naohiko Nakanishi,Noriyuki Wakana,Arito Yukawa,Norimasa Taniguchi,Hirokazu Yokoi, Kiyonari Matsuo,Natsuya Keira, Takashi Okada,Keizo Furukawa,Masahiro Koide,Satoaki Matoba,

    BACKGROUND:The clinical consequences of discontinuing proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have not been elucidated. METHODS AND RESULTS:We analyzed 208 patients with coronary artery disease treated with PCSK9 inhibitors. During a median follow-up of 1,096 days, 94 patients discontinued treatment and they had a higher incidence of major adverse cardiovascular events (MACE) than those who continued. Event curves diverged approximately 3 years after discontinuation. Multivariable Cox analysis showed that discontinuation was associated with a higher incidence of MACE. CONCLUSIONS:Discontinuation of PCSK9 inhibitors was associated with worse cardiovascular outcomes.

    2026Circulation journal official journal of the Japanese Circulation Society(2026)引用:1
    引用
    AI阅读
    加入学术空间
    5Validation of the 2019 EULAR/ACR Classification Criteria and Clinical Characteristics of Childhood-Onset Japanese Patients with Systemic Lupus Erythematosus.
    Hitoshi Irabu,Asami Ohara,Aki Nakamura,Hidehiko Narazaki, Yuko Hayashi,Yuichi Yamasaki,Naomi Iwata,Shiro Ohshima,Susumu Nishiyama,Yasuo Nakagishi,Daisuke Fukuhara,Hiroyuki Ishida,

    OBJECTIVES:This study aimed to evaluate the diagnostic performance of the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR-2019) classification criteria of systemic lupus erythematosus (SLE) and to clarify the clinical characteristics of Japanese childhood-onset SLE (cSLE). METHODS:We retrospectively analyzed clinical data registered in the Paediatric Rheumatology International Collaboration Unit Registry (PRICURE) version 2 up to March 31, 2023. Frequencies of individual items within the EULAR/ACR-2019 criteria were compared with those observed in a Japanese adult SLE cohort. RESULTS:A total of 105 patients with cSLE, 19 with Juvenile dermatomyositis (JDM), 27 with primary Sjögren's disease (pSjD), and 9 with mixed connective-tissue disease (MCTD) were included. The sensitivity of the EULAR/ACR-2019 criteria was 97.1%. The specificity was 94.7% for JDM, 92.6% for pSjD, 55.6% for MCTD, and 87.3% for all disease controls. cSLE patients in this cohort more frequently exhibited renal involvement, low serum C3 or C4 levels, and positivity for antiphospholipid and anti-double-stranded DNA antibodies, but joint symptoms were less common than in adult SLE patients. CONCLUSIONS:Although the EULAR/ACR-2019 criteria are generally applicable, the limited specificity for MCTD necessitates careful differential diagnosis. Japanese cSLE is commonly characterized by renal involvement, hypocomplementemia, and SLE-related autoantibody positivity.

    2026Modern rheumatology(2026)引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 938 篇论文

    合作机构(100)

    京都大学合作论文 240
    京都府立医科大学合作论文 142
    京都桂病院合作论文 67
    Osaka Red Cross Hospital,Japanese Red Cross Society, Japan合作论文 59
    Tenri Hospital合作论文 55
    Hyogo Prefectural Amagasaki General Medical Center合作论文 45
    Kobe City Medical Center General Hospital合作论文 44
    倉敷中央病院合作论文 42
    Japanese Red Cross Society Wakayama Medical Center,Japanese Red Cross Society, Japan合作论文 39
    京都第一赤十字病院合作论文 34

    机构统计